National Institutes of Health
Molecular Imaging of Inflammation in Cancer (R01 Clinical Trial Not Allowed)
Molecular Imaging of Inflammation in Cancer (R01 Clinical Trial Not Allowed) is a funding opportunity from National Institutes of Health, closing January 7, 2028.
Overview
The purpose of this Notice of Funding Opportunity (NOFO) is to invite research grant applications (R01) for the development and use of current and emerging molecular imaging methods to gain fundamental insights into cancer inflammation in vivo. The motivation for this initiative is that much of current imaging…